154 results match your criteria: "and Manchester University NHS Foundation Trust[Affiliation]"

Background: Beta-2 agonists play an important role in the management of asthma. Inhaled long-acting beta-2 agonists (LABAs) and short-acting beta-2 agonists (SABAs) cause bronchodilation by stimulating adrenoceptors. These receptors are also present in cardiac cells and, as a side effect, could also be stimulated by inhaled beta-2 agonists.

View Article and Find Full Text PDF

Exploring the genetics of airflow limitation in lung function across the lifespan - a polygenic risk score study.

EClinicalMedicine

September 2024

Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Sjukhusbacken 10, 118 83, Stockholm, Sweden.

Article Synopsis
  • Chronic obstructive pulmonary disease (COPD) can be influenced by genetic factors and may stem from reduced lung growth during childhood, leading to lower lung function throughout life.
  • A polygenic risk score (PRS) was calculated using data from a large genome-wide association study and tested for its correlation with lung function in individuals aged 4-50 from multiple research cohorts.
  • Results indicated that higher PRS scores were associated with significantly lower lung function, measured by key indicators, starting from childhood and continuing into adulthood, regardless of smoking, sex, or asthma diagnosis.
View Article and Find Full Text PDF

Type 2 inflammation in COPD: is it just asthma?

Breathe (Sheff)

October 2024

Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.

COPD is a heterogeneous condition, with tobacco smoking being the main environmental risk factor. The presence of type 2 (T2) inflammation is a well-recognised feature of asthma; however, it is now apparent that a subset of COPD patients also displays evidence of T2 inflammation with respect to elevated eosinophil counts and altered gene and protein expression of several T2 inflammatory mediators. T2 inflammatory mediators represent an attractive therapeutic target in both COPD and asthma; however, the efficacy of pharmaceutical interventions varies between diseases.

View Article and Find Full Text PDF
Article Synopsis
  • - The development of the CompOsite iNdexes For Response in asthMa (CONFiRM) aimed to create patient-centered tools that measure responses to biologics for severe asthma in both adults and children, integrating clinical data and quality of life (QoL) indicators.
  • - Experts and patients collaborated to identify significant outcome changes and devised CONFiRM scores, which demonstrated high levels of agreement on key factors, with patients emphasizing the importance of quality of life more than healthcare professionals did.
  • - The CONFiRM scores effectively measure treatment response, with strong validity metrics indicating their reliability, and they facilitate a comprehensive assessment of biologics’ effectiveness; further studies are required for prospective validation.
View Article and Find Full Text PDF

Fungal diseases represent a considerable global health concern, affecting >1 billion people annually. In response to this growing challenge, the World Health Organization introduced the pivotal fungal priority pathogens list (FPPL) in late 2022. The FPPL highlights the challenges in estimating the global burden of fungal diseases and antifungal resistance (AFR), as well as limited surveillance capabilities and lack of routine AFR testing.

View Article and Find Full Text PDF

The relevance of eosinophils in chronic obstructive pulmonary disease: inflammation, microbiome, and clinical outcomes.

J Leukoc Biol

November 2024

Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester and Manchester University NHS Foundation Trust, Manchester, M23 9LT, United Kingdom.

Chronic obstructive pulmonary disease is caused by the inhalation of noxious particles such as cigarette smoke. The pathophysiological features include airway inflammation, alveolar destruction, and poorly reversible airflow obstruction. A subgroup of patients with chronic obstructive pulmonary disease has higher blood eosinophil counts, associated with an increased response to inhaled corticosteroids and increased biomarkers of pulmonary type 2 inflammation.

View Article and Find Full Text PDF

Background: A diagnosis of COPD is mainly considered in individuals with >10 pack-years of smoking. We tested the hypothesis that low smoking exposure, below the critical threshold of 10 pack-years, increases risk of COPD and leads to poor prognosis.

Methods: We followed non-obstructed adult smokers from the Copenhagen City Heart Study for COPD, defined as a forced expiratory volume in 1 s (FEV)/forced vital capacity <0.

View Article and Find Full Text PDF

The effect of inhaler prescription on the development of lung cancer in COPD: a nationwide population-based study.

Respir Res

May 2024

Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Worldcup-ro 164, Suwon, Gyeonggi-do, 16499, Republic of Korea.

Article Synopsis
  • COPD is linked to an increased risk of lung cancer, but the impact of inhaled corticosteroids (ICS) on this risk is unclear, prompting a study to investigate the relationship between inhaler prescriptions and comorbidities in COPD patients.
  • A retrospective analysis of over 63,000 COPD patients found no significant difference in lung cancer development among those using different types of inhalers; rather, factors like diffuse interstitial lung disease, comorbidity scores, and hospitalization rates were more impactful.
  • The study concluded that lung cancer risk in COPD patients is more strongly influenced by existing health issues and hospitalization frequency than the type of inhaler prescribed.
View Article and Find Full Text PDF

Background: Studies reporting on the incidence of sudden cardiac arrest and/or death (SCA/D) in athletes commonly lack methodological and reporting rigor, which has implications for screening and preventative policy in sport. To date, there are no tools designed for assessing study quality in studies investigating the incidence of SCA/D in athletes.

Methods And Results: The International Criteria for Reporting Study Quality for Sudden Cardiac Arrest/Death tool (IQ-SCA/D) was developed following a Delphi process.

View Article and Find Full Text PDF

Advances in COPD imaging using CT and MRI: linkage with lung physiology and clinical outcomes.

Eur Respir J

May 2024

Division of Infection, Immunity and Respiratory Medicine, The University of Manchester and Manchester University NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.

Article Synopsis
  • * Magnetic resonance imaging (MRI) has emerged as a valuable tool for assessing both structural and functional lung issues without radiation, particularly beneficial for early detection in smokers and COPD patients.
  • * These imaging techniques allow for comprehensive evaluations of lung structure and function, helping to better understand disease patterns and guide treatment decisions.
View Article and Find Full Text PDF

Exhaled nitric oxide levels in COPD patients who use electronic cigarettes.

Nitric Oxide

April 2024

Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK; Medicines Evaluation Unit, The Langley Building, Southmoor Road, Manchester, UK.

Emerging data from clinical studies have shown pro-inflammatory effects associated with e-cigarette use. Fractional exhaled nitric oxide (FeNO) is a biomarker of pulmonary type 2 (T2) inflammation. The effect of chronic e-cigarette use on FeNO is unclear.

View Article and Find Full Text PDF

Symptomatic bradyarrhythmias in the athlete-Underlying mechanisms and treatments.

Heart Rhythm

August 2024

Division of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom; National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Bradyarrhythmias including sinus bradycardia and atrioventricular (AV) block are frequently encountered in endurance athletes especially at night. While these are well tolerated by the young athlete, there is evidence that generally from the fifth decade of life onward, such arrhythmias can degenerate into pathological symptomatic bradycardia requiring pacemaker therapy. For many years, athletic bradycardia and AV block have been attributed to high vagal tone, but work from our group has questioned this widely held assumption and demonstrated a role for intrinsic electrophysiological remodeling of the sinus node and the AV node.

View Article and Find Full Text PDF

Introduction: Athletic training can result in electrical and structural changes of the right ventricle that may mimic phenotypical features of arrhythmogenic right ventricular cardiomyopathy (ARVC), such as T-wave inversion and right heart dilatation. An erroneous interpretation may have consequences ranging from false reassurance in an athlete vulnerable to cardiac arrhythmias, to unnecessary sports restriction in a healthy individual. The primary aim of this study was to define normal RV dimension reference ranges for academy adolescent footballers of different ethnicities.

View Article and Find Full Text PDF

The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohort.

ERJ Open Res

January 2024

Research and Early Development, Respiratory and Immunology, AstraZeneca, Cambridge, UK.

Background: The diagnosis of COPD requires the demonstration of non-fully reversible airflow limitation by spirometry in the appropriate clinical context. Yet, there are patients with symptoms and relevant exposures suggestive of COPD with either normal spirometry (pre-COPD) or preserved ratio but impaired spirometry (PRISm). Their prevalence, clinical characteristics and associated outcomes in a real-life setting are unclear.

View Article and Find Full Text PDF

Current smoking reduces small airway eosinophil counts in COPD.

ERJ Open Res

January 2024

Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.

https://bit.ly/49YSKwG.

View Article and Find Full Text PDF

Background: The distances that patients have to travel can influence their access to cancer treatment. We investigated the determinants of travel time, separately for journeys by car and public transport, to centres providing radical surgery or radiotherapy for prostate cancer.

Methods: Using national cancer registry records linked to administrative hospital data, we identified patients who had radical surgery or radiotherapy for prostate cancer between January 2017 and December 2018 in the English National Health Service.

View Article and Find Full Text PDF

Population-based interventions for preventing falls and fall-related injuries in older people.

Cochrane Database Syst Rev

January 2024

NIHR Applied Research Collaboration Greater Manchester, School of Health Sciences, The University of Manchester, and Manchester Academic Health Science Centre, and Manchester University NHS Foundation Trust, Manchester, UK.

Article Synopsis
  • About one-third of older adults aged 65 and older fall each year, prompting the need for community-wide interventions that address the broader factors contributing to these falls, such as environmental hazards and lack of physical activity.
  • These interventions may include policies for increased vitamin D intake, reducing hazards in homes and communities, and promoting public health programs that encourage exercise among older adults.
  • The study aimed to review evidence on the effectiveness of these population-based interventions by analyzing randomized controlled trials and other relevant studies, focusing on strategies that benefit entire communities rather than just individuals at high risk.
View Article and Find Full Text PDF

It is increasingly recognized that adults with preserved ratio impaired spirometry (PRISm) are prone to increased morbidity. However, the underlying pathophysiological mechanisms are unknown. Evaluate the mechanisms of increased dyspnea and reduced exercise capacity in PRISm.

View Article and Find Full Text PDF

Due to a plethora of risk factors, including prematurity, neonates are at risk for acute kidney injury (AKI) and, once established, AKI is associated with poor outcomes. The most widely used AKI biomarker is creatinine, despite research demonstrating creatinine to be a suboptimal tool for diagnosing neonatal AKI. This article uses an amalgamated case study to illustrate the inadequacies of creatinine for detection of preterm AKI and to present a range of novel AKI biomarkers relevant to the neonatal population.

View Article and Find Full Text PDF

Exhaled nitric oxide, eosinophils and current smoking in COPD patients.

ERJ Open Res

November 2023

Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.

https://bit.ly/3PSWvM2.

View Article and Find Full Text PDF

Atopic dermatitis (AD) is a common inflammatory skin condition and prior genome-wide association studies (GWAS) have identified 71 associated loci. In the current study we conducted the largest AD GWAS to date (discovery N = 1,086,394, replication N = 3,604,027), combining previously reported cohorts with additional available data. We identified 81 loci (29 novel) in the European-only analysis (which all replicated in a separate European analysis) and 10 additional loci in the multi-ancestry analysis (3 novel).

View Article and Find Full Text PDF

Background: Numerous risk scores have been developed to predict childhood asthma. However, they may not predict asthma beyond childhood. We aim to create childhood risk scores that predict development and persistence of asthma up to young adult life.

View Article and Find Full Text PDF